BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3338031)

  • 1. Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction.
    Coia LR; Paul AR; Engstrom PF
    Cancer; 1988 Feb; 61(4):643-9. PubMed ID: 3338031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
    Coia LR; Engstrom PF; Paul A
    J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
    Coia LR; Engstrom PF; Paul AR; Stafford PM; Hanks GE
    Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):29-36. PubMed ID: 1704362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.
    Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N
    Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of combined radiotherapy and chemotherapy for esophageal carcinoma.
    Coia LR; Engstrom PF; Paul A; Gallagher MJ; Stoll D; Catalano R; Richter MP
    Am J Clin Oncol; 1984 Dec; 7(6):653-9. PubMed ID: 6084954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study.
    John M; Flam M; Wittlinger P; Mowry PA
    Am J Clin Oncol; 1987 Aug; 10(4):310-6. PubMed ID: 2441591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction.
    Lokich JJ; Shea M; Chaffey J
    Cancer; 1987 Aug; 60(3):275-9. PubMed ID: 3594364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
    Burmeister BH; Denham JW; O'Brien M; Jamieson GG; Gill PG; Devitt P; Yeoh E; Hamilton CS; Ackland SP; Lamb DS
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):997-1006. PubMed ID: 7607974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
    Algan O; Coia LR; Keller SM; Engstrom PF; Weiner LM; Schultheiss TE; Hanks GE
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):753-61. PubMed ID: 7790262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
    Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
    Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of continuous infusion carboplatin, 5-fluorouracil, and radiotherapy for localized cancer of the esophagus.
    Jefford M; Toner GC; Smith JG; Ngan SY; Rischin D; Guiney MJ
    Am J Clin Oncol; 2002 Jun; 25(3):277-82. PubMed ID: 12040288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma.
    Stewart FM; Harkins BJ; Hahn SS; Daniel TM
    Cancer; 1989 Aug; 64(3):622-8. PubMed ID: 2501018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonoperative therapy for squamous-cell cancer of the esophagus.
    Leichman L; Herskovic A; Leichman CG; Lattin PB; Steiger Z; Tapazoglou E; Rosenberg JC; Arbulu A; Asfaw I; Kinzie J
    J Clin Oncol; 1987 Mar; 5(3):365-70. PubMed ID: 2434626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of mitomycin in esophageal cancer.
    Coia LR
    Oncology; 1993 Apr; 50 Suppl 1():53-60. PubMed ID: 8483558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction.
    Schnirer II; Komaki R; Yao JC; Swisher S; Putnam J; Pisters PW; Roth JA; Ajani JA
    Am J Clin Oncol; 2001 Feb; 24(1):91-5. PubMed ID: 11232959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
    Wolf M; Zehentmayr F; Niyazi M; Ganswindt U; Haimerl W; Schmidt M; Hölzel D; Belka C
    Strahlenther Onkol; 2010 Jul; 186(7):374-81. PubMed ID: 20582393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
    Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
    Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
    Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM
    Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.